K2M Group Holdings Inc (KTWO) Shares Sold by King Luther Capital Management Corp
King Luther Capital Management Corp lessened its holdings in shares of K2M Group Holdings Inc (NASDAQ:KTWO) by 66.0% during the 4th quarter, Holdings Channel reports. The firm owned 47,930 shares of the medical device company’s stock after selling 93,000 shares during the period. King Luther Capital Management Corp’s holdings in K2M Group were worth $863,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in KTWO. Cubist Systematic Strategies LLC grew its holdings in shares of K2M Group by 7,765.0% during the third quarter. Cubist Systematic Strategies LLC now owns 4,719 shares of the medical device company’s stock worth $100,000 after purchasing an additional 4,659 shares during the last quarter. Teacher Retirement System of Texas bought a new stake in shares of K2M Group during the fourth quarter worth $213,000. Trexquant Investment LP bought a new stake in shares of K2M Group during the third quarter worth $223,000. Quantbot Technologies LP grew its holdings in shares of K2M Group by 275.9% during the third quarter. Quantbot Technologies LP now owns 10,593 shares of the medical device company’s stock worth $224,000 after purchasing an additional 7,775 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. acquired a new position in shares of K2M Group during the third quarter valued at $347,000.
K2M Group Holdings Inc (KTWO) opened at $19.34 on Friday. K2M Group Holdings Inc has a one year low of $16.44 and a one year high of $25.99. The company has a quick ratio of 1.67, a current ratio of 3.06 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $815.69, a PE ratio of -22.23 and a beta of 1.42.
Several equities analysts have recently issued reports on KTWO shares. Wells Fargo & Co lowered K2M Group from an “outperform” rating to a “market perform” rating and set a $23.00 price target on the stock. in a research note on Monday, December 4th. Oppenheimer reaffirmed a “buy” rating and set a $24.00 price target on shares of K2M Group in a research note on Friday, November 10th. Needham & Company LLC lowered K2M Group from a “strong-buy” rating to a “buy” rating and cut their price target for the company from $26.00 to $20.00 in a research note on Friday, December 8th. Zacks Investment Research lowered K2M Group from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Finally, Barclays reaffirmed a “buy” rating and set a $25.00 price target on shares of K2M Group in a research note on Tuesday, January 9th. One research analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company. K2M Group has an average rating of “Buy” and a consensus price target of $24.50.
TRADEMARK VIOLATION WARNING: This report was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.watchlistnews.com/k2m-group-holdings-inc-ktwo-shares-sold-by-king-luther-capital-management-corp/1904523.html.
K2M Group Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Want to see what other hedge funds are holding KTWO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for K2M Group Holdings Inc (NASDAQ:KTWO).
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.